Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

Maja Matic, Marga Nijenhuis*, Bianca Soree, Nienke J. de Boer-Veger, Anne Marie Buunk, Elisa J.F. Houwink, Hans Mulder, Gerard A.P.J.M. Rongen, Jan van der Weide, Bob Wilffert, Jesse J. Swen, Henk Jan Guchelaar, Vera H.M. Deneer, Ron H.N. van Schaik

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

Correction to: European Journal of Human Genetics https://doi.org/10.1038/s41431-021-00920-y, published online 15 July 2021

Original languageEnglish
Article number1196
JournalEuropean Journal of Human Genetics
Volume30
Early online date27 Sept 2021
DOIs
Publication statusPublished - 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to European Society of Human Genetics 2021

Fingerprint

Dive into the research topics of 'Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)'. Together they form a unique fingerprint.

Cite this